[HTML][HTML] The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
C Patel, JML Brotherton, A Pillsbury… - …, 2018 - eurosurveillance.org
Background: A National human papilloma virus (HPV) Vaccination Programme for the
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …
Present status of human papillomavirus vaccine development and implementation
R Herrero, P González, LE Markowitz - The Lancet Oncology, 2015 - thelancet.com
Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia
JM Palefsky, AR Giuliano, S Goldstone… - … England Journal of …, 2011 - Mass Medical Soc
Background The rate of anal cancer is increasing among both women and men, particularly
men who have sex with men. Caused by infection with human papillomavirus (HPV) …
men who have sex with men. Caused by infection with human papillomavirus (HPV) …
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males
AR Giuliano, JM Palefsky, S Goldstone… - … England Journal of …, 2011 - Mass Medical Soc
Background Infection with human papillomavirus (HPV) and diseases caused by HPV are
common in boys and men. We report on the safety of a quadrivalent vaccine (active against …
common in boys and men. We report on the safety of a quadrivalent vaccine (active against …
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
JML Brotherton, M Fridman, CL May, G Chappell… - The Lancet, 2011 - thelancet.com
Background Australia introduced a human papillomavirus (HPV) vaccination programme
with the quadrivalent HPV vaccine for all women aged 12–26 years between 2007 and …
with the quadrivalent HPV vaccine for all women aged 12–26 years between 2007 and …
[HTML][HTML] Malaria surveillance—United States, 2015
KE Mace - MMWR. Surveillance Summaries, 2018 - cdc.gov
Abstract Problem/Condition: Malaria in humans is caused by intraerythrocytic protozoa of the
genus Plasmodium. These parasites are transmitted by the bite of an infective female …
genus Plasmodium. These parasites are transmitted by the bite of an infective female …
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
Background Quadrivalent human papillomavirus (HPV) vaccine has high efficacy in clinical
trials but no reports describe its effects at a population level. From July, 2007, Australia was …
trials but no reports describe its effects at a population level. From July, 2007, Australia was …
The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme
Background Australia provided free quadrivalent human papillomavirus vaccines to 12–18-
year-old girls and women aged≤ 26 years from mid-2007 until the end of 2009. After this …
year-old girls and women aged≤ 26 years from mid-2007 until the end of 2009. After this …
[HTML][HTML] HPV-immune response to infection and vaccination
M Stanley - Infectious agents and cancer, 2010 - Springer
HPV infection in the genital tract is common in young sexually active individuals, the majority
of whom clear the infection without overt clinical disease. However most of those who …
of whom clear the infection without overt clinical disease. However most of those who …
Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program
L Baandrup, M Blomberg, C Dehlendorff… - Sexually transmitted …, 2013 - journals.lww.com
Background Approximately 90% of genital warts (GWs) are caused by human
papillomavirus (HPV) types 6 and 11. Denmark has provided the quadrivalent HPV vaccine …
papillomavirus (HPV) types 6 and 11. Denmark has provided the quadrivalent HPV vaccine …